Author

Afzal Nagani

Observed name: Nagani, Afzal

Institution: Parul University

Observed institution: Parul University

ORCID: 0000-0002-9016-1507

Observed ORCID: 0000-0002-9016-1507

OpenAlex ID: A5036569238

A review on synthetic investigation for quinoline- recent green approaches

2022 · Ashish Patel, Stuti Patel, et al. · Green Chemistry Letters and Reviews · 77

Indole-based COX-2 inhibitors: A decade of advances in inflammation, cancer, and Alzheimer’s therapy

2024 · Moksh Shah, Rakshita Parmar, et al. · Bioorganic Chemistry · 35

Benzimidazole as Ubiquitous Structural Fragment: An Update on Development of its Green Synthetic Approaches

2020 · Ashish Patel, Drashti Shah, et al. · Mini-Reviews in Organic Chemistry · 28

Unveiling piperazine-quinoline hybrids as potential multi-target directed anti-Alzheimer’s agents: design, synthesis and biological evaluation

2024 · Afzal Nagani, Moksh Shah, et al. · Molecular Diversity · 21

PDF

The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer’s Disease

2020 · Hirak Shah, Ashish Patel, et al. · CNS & Neurological Disorders - Drug Targets · 21

Eco-friendly Approaches to Chromene Derivatives: A Comprehensive Review of Green Synthesis Strategies

2024 · Vidhi Patel, Tushar Bambharoliya, et al. · Current Topics in Medicinal Chemistry · 18

Pyrazolopyridine pyrimidone hybrids as potential DprE1 inhibitors, design, synthesis and biological evaluation as antitubercular agents

2025 · Moksh Shah, Iva Patel, et al. · Scientific Reports · 16

PDF

Pharmacophore mapping, 3D QSAR, molecular docking, and ADME prediction studies of novel Benzothiazinone derivatives

2024 · Jahaan Shaikh, Salman Patel, et al. · In Silico Pharmacology · 13

PDF

Piperazinyl-N-aryl acetamides and 1,3,4-thiadiazole Hybrids as Potential DprE1 Inhibitors: Design, Synthesis and Biological Evaluation as antitubercular agents

2025 · Payal Patel, Moksh Shah, et al. · Journal of Molecular Structure · 10

Recent advances in piperazine derivatives as antibacterial agents: a comprehensive review (2020–2024)

2025 · Kripa Patel, Moksh Shah, et al. · Molecular Diversity · 9

Design, synthesis and biological evaluation of some imidazo[1,2- a ]pyridine derivatives as anti-tubercular agents: an in silico – in vitro approach

2024 · Harnisha Patel, Afzal Nagani, et al. · Journal of Biomolecular Structure and Dynamics · 8

New Quinazolinone‐Thiouracil Derivatives: Design, Synthesis, Anticancer Evaluation, and In Silico Analysis

2024 · Dolly Parmar, Rati Kailash Prasad Tripathi, et al. · ChemistrySelect · 8

Oxadiazoles as multi-target therapeutic agents in Alzheimer’s Disease: A review of cholinesterase, MAO, β-Secretase, and Aβ aggregation inhibition

2025 · Moksh Shah, Chanchal Singh, et al. · Journal of Saudi Chemical Society · 7

PDF

Sustainable Synthesis of Phenazines: A Review of Green Approaches

2023 · Drashti Shah, Tushar Bambharoliya, et al. · Current Organic Chemistry · 7

Sustainable synthesis of piperazine analogs using varied energy sources in the petasis reaction: A green chemistry perspective

2024 · Afzal Nagani, Moksh Shah, et al. · Indian Journal of Heterocyclic Chemistry · 5

Molecular Modelling, Synthesis and Biological Evaluation of Novel Benzimidazole Derivatives for the Treatment of Breast Cancer

2020 · Ishan Panchal, Animesh G. Devgirkar, et al. · Current Chinese chemistry · 5

Advances in 1,3,4-thiadiazole-based cholinesterase inhibitors: toward novel therapeutics for Alzheimer’s disease

2026 · Moksh Shah, Kripa Patel, et al. · Molecular Diversity · 3

A Review on the Synthetic Approach of Marinopyrroles: A Natural Antitumor Agent from the Ocean

2020 · Ashish Patel, Hirak Shah, et al. · Letters in Organic Chemistry · 3

Design, synthesis and antitubercular evaluation of novel 5,6-diphenyl-1,2,4-triazine-piperazine derivatives targeting mycobacterial dihydrofolate reductase: Original scientific article

2026 · Uday Thakkar, Moksh Shah, et al. · ADMET & DMPK · 2

PDF

Exploring imidazo[1,2-a]pyridine hybrids in cancer therapy: ADMET profiling, molecular docking, MD simulations and DFT calculations

2026 · Drashti Shah, Afzal Nagani, et al. · Scientific Reports · 2

PDF

Design, Synthesis, and Biological Evaluation of Natural Carbolic Acid‐Pyrazinamide Hybrids as Antimicrobial Agents

2025 · Kripa Patel, Afzal Nagani, et al. · ChemistrySelect · 2

In silico analysis, synthesis and biological evaluation of DHFR inhibitors

2021 · Chaitali Lad, Ishan Panchal, et al. · Folia Medica · 2

PDF

Benzothiazole‐Based Anti‐Alzheimer's Agents: A Comprehensive Review of Developments from 2015 to 2025

2026 · Moksh Shah, Sudhanshu Sinha, et al. · The Chemical Record · 1

Design, Synthesis, and Biological Evaluation of Novel 6,8-Disubstituted Imidazo[1,2-a]pyridine Derivatives as a CDK2 Inhibitors

2023 · Ashish Patel, Bhargav Bhimani, et al. · Heterocycles · 1

PDF

Quinazoline-based VEGFR-2 Inhibitors: A Comprehensive Review of Design Strategies, SAR, and Therapeutic Advances

2026 · Adarsh Kumar Yadav, Drashti Shah, et al. · Current Drug Targets

Works count: 30

Citation count: 304

H-index: 9

I10-index: 9